Cargando…
Shortcomings in the Current Amyotrophic Lateral Sclerosis Trials and Potential Solutions for Improvement
Amyotrophic lateral sclerosis (ALS) is a clinically progressive neurodegenerative syndrome predominantly affecting motor neurons and their associated tracts. Riluzole and edaravone are the only FDA certified drugs for treating ALS. Over the past two decades, almost all clinical trials aiming to deve...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5626834/ https://www.ncbi.nlm.nih.gov/pubmed/29033893 http://dx.doi.org/10.3389/fneur.2017.00521 |